Stock listing

NASDAQ:CMRX Chimerix Inc Stock

Follow Chimerix Inc into a list and get an email when it puts out news.

Last close · NASDAQ:CMRX

$8.54 USD

Close on Apr 17, 2025 · No longer trades

Apr 11, 2013 to last close -54.6% · monthly closes, Apr 11, 2013 – Apr 17, 2025
Lowest – highest close
$0.771 – $57.43 USDSince Apr 11, 2013 · lowest Aug 13, 2024 · highest Aug 5, 2015

Delisted NASDAQ:CMRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CMRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Chimerix Inc on 6ix

Calls
16 calls with a replay · 16 with a transcript · latest Nov 7, 2024
Decks
17 decks · latest Dec 10, 2024

Events

CallWhenStatus
Chimerix (CMRX) Q3 2024 Earnings CallThu, Nov 07, 2024 · 8:30 AM ETReplay
Chimerix (CMRX) Q2 2024 Earnings CallTue, Aug 13, 2024 · 8:30 AM ETReplay
Chimerix (CMRX) Q1 2024 Earnings CallWed, May 01, 2024 · 8:30 AM ETReplay
Chimerix (CMRX) Q4 2023 Earnings CallThu, Feb 29, 2024 · 8:30 AM ETReplay
Chimerix (CMRX) Q3 2023 Earnings CallThu, Nov 02, 2023 · 8:30 AM ETReplay
Chimerix (CMRX) Q2 2023 Earnings CallThu, Aug 03, 2023 · 8:30 AM ETReplay
Chimerix (CMRX) Q1 2023 Earnings CallThu, May 04, 2023 · 8:30 AM ETReplay
Chimerix (CMRX) Q4 2022 Earnings CallThu, Mar 02, 2023 · 8:30 AM ETReplay
Chimerix (CMRX) Q3 2022 Earnings CallThu, Nov 03, 2022 · 8:30 AM ETReplay
Chimerix (CMRX) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
All 16 calls
CallWhenStatus
Chimerix (CMRX) Q1 2022 Earnings CallMon, May 16, 2022 · 8:30 AM ETReplay
Chimerix (CMRX) Q4 2021 Earnings CallTue, Mar 01, 2022 · 8:30 AM ETReplay
Chimerix (CMRX) Q3 2021 Earnings CallThu, Nov 04, 2021 · 8:30 AM ETReplay
Chimerix (CMRX) Q2 2021 Earnings CallThu, Aug 05, 2021 · 8:30 AM ETReplay
Chimerix (CMRX) Q1 2021 Earnings CallThu, May 06, 2021 · 8:30 AM ETReplay
Chimerix (CMRX) Q4 2020 Earnings CallThu, Feb 25, 2021 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2024)Investor deck39 slidesDec 10, 2024
Investor Presentation (November 2024)Investor deck35 slidesNov 7, 2024
Investor Presentation (August 2024)Investor deck35 slidesAug 13, 2024
Investor Presentation (May 2024)Investor deck29 slidesMay 1, 2024
Investor Presentation (February 2024)Investor deck29 slidesFeb 29, 2024
Investor Presentation (November 2023)Investor deck42 slidesNov 2, 2023
Investor Presentation (August 2023)Investor deck43 slidesAug 3, 2023
Investor Presentation (May 2023)Investor deck41 slidesMay 4, 2023
Investor Presentation (March 2023)Investor deck38 slidesMar 2, 2023
41st Annual J.P. Morgan Healthcare Conference (January 2023)Conference20 slidesJan 12, 2023
All 17 decks
DeckKindSlidesDate
Investor Presentation (December 2022)Investor deck34 slidesDec 9, 2022
Corporate Update (November 2021)Corporate update32 slidesNov 22, 2021
Merger or Acquisition (January 2021)Merger or acquisition26 slidesJan 8, 2021
Cowen Healthcare Conference 2019Conference20 slidesMar 11, 2019
J.P. Morgan Healthcare Conference 2018Conference25 slidesJan 10, 2018
Investor Presentation (November 2017)Investor deck50 slidesNov 14, 2017
Investor Presentation (January 2017)Investor deck29 slidesJan 6, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Patrick Machado
Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past)
Director · Jun 20, 2014 – Jun 9, 2023 · Past
Fred A Middleton
Other companies: CalciMedica, Inc. (Director · Since at least Mar 20, 2023); Stereotaxis, Inc. (Director · Jan 3, 2012 – Mar 2, 2018 · Past); Endocyte Inc (Director · Dec 16, 2011 – Dec 21, 2018 · Past); Pacira BioSciences, Inc. (Director · Nov 21, 2011 – Jun 21, 2013 · Past)
Director · Mar 28, 2018 – Apr 21, 2025 · Past
Martha Demski
Other companies: Alpha Teknova, Inc. (Board Member · Since at least Aug 31, 2023); Equillium, Inc. (Director · Since at least May 24, 2022); ADMA Biologics Inc (Director · Mar 6, 2023 – Mar 6, 2023 · Past)
Director · May 17, 2022 – Apr 21, 2025 · Past
Michael Sherman
Other companies: Aktis Oncology, Inc. (Director · Since at least Jan 8, 2026); Werewolf Therapeutics, Inc. (Director · Since at least May 24, 2024)
Chief Executive Officer, Director · Jun 20, 2024 – Apr 21, 2025 · Past
Victoria Vakiener
Other companies: Arrowhead Pharmaceuticals, Inc. (Director · Since at least May 2, 2022); Epizyme Inc (Chief Commercial Officer · Sep 18, 2020 – Feb 4, 2021 · Past)
Director · Apr 22, 2021 – Apr 21, 2025 · Past
Lisa Lynn Decker
Other companies: IGM Biosciences Inc (CHIEF BUSINESS OFFICER · Since at least Jun 16, 2025)
Director · Apr 21, 2025 – Apr 21, 2025 · Past
Michael T Andriole
Other companies: Endocyte Inc (Chief Financial Officer · Oct 4, 2017 – Dec 21, 2018 · Past)
PRESIDENT AND CEO, Director · Apr 8, 2019 – Apr 21, 2025 · Past
Robert J. Meyer
Other companies: Avalyn Pharma Inc. (Director · Since at least Sep 15, 2026)
Director · Jun 20, 2024 – Apr 21, 2025 · Past
W. Garrett Nichols
Other companies: Candel Therapeutics, Inc. (Chief Medical Officer · Since at least Sep 12, 2022)
Chief Medical Officer · Sep 2, 2014 – Feb 7, 2020 · Past
Allen S MelemedCHIEF MEDICAL OFFICER · Apr 21, 2025 – Apr 21, 2025 · Past
All 16 people
PersonSeat
Catherine GillissDirector · Jun 23, 2022 – Jun 9, 2023 · Past
David JakemanVP OF FINANCE AND ACCOUNTING · Jun 20, 2019 – Apr 21, 2025 · Past
Michael Albert AlrutzSVP AND GENERAL COUNSEL · Feb 5, 2019 – Apr 21, 2025 · Past
Thomas J RigaCOO and CCO · Apr 21, 2025 – Apr 21, 2025 · Past
Timothy WollaegerDirector · Apr 10, 2013 – Mar 2, 2016 · Past
Wende S HuttonDirector · Apr 10, 2013 – Oct 23, 2013 · Past

Open People

Log in to ask 6ix AI your own questions about Chimerix Inc.